The hemostasis and tissue sealing agents market has seen steady growth, in part due to aggressive marketing. New hemostat and tissue sealing agents are regularly introduced and meet a wide range of needs in surgery and other medical applications. Tissue sealants have been especially successful because of a rise in the geriatric population and a corresponding need for sealing methods that minimize post-operative complications and speed healing. In the future, growth may be slowed by cost and strict regulatory requirements. However, adhesives and sealants account for 36% of the total hemostasis and tissue sealing agents market in North America, with continued growth expected. The Asia Pacific region is expected to have the fastest growth in the coming years. Major manufacturers in the hemostasis and tissue sealing market include CryoLife, Inc., Johnson & Johnson, Baxter, Advance Medical Solution Group, and Cohera Medical, Inc.